Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. R. Gibson

Letter: Bias in Clinical Trials of the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome-Getting the Facts Right

Alimentary Pharmacology and Therapeutics

English

Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors

Alimentary Pharmacology and Therapeutics

English

Intra-Patient Variability in Adalimumab Drug Levels Within and Between Cycles in Crohn's Disease

Alimentary Pharmacology and Therapeutics

English

Editorial: Variability in Adalimumab Trough and Peak Serum Concentrations - Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Systematic Review: Exercise-Induced Gastrointestinal Syndrome-Implications for Health and Intestinal Disease

Alimentary Pharmacology and Therapeutics

English

Review Article: Short Chain Fatty Acids as Potential Therapeutic Agents in Human Gastrointestinal and Inflammatory Disorders

Alimentary Pharmacology and Therapeutics

English

Randomised Clinical Trial: Efficacy, Safety and Dosage of Adjunctive Allopurinol in Azathioprine/Mercaptopurine Nonresponders (AAA Study)

Alimentary Pharmacology and Therapeutics

English

Editorial: Rethinking Predictors of Response to the Low FODMAP Diet - Should We Retire Fructose and Lactose Breath-Hydrogen Testing and Concentrate on Visceral Hypersensitivity?

Alimentary Pharmacology and Therapeutics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. R. Gibson

Letter: Bias in Clinical Trials of the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome-Getting the Facts Right

Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors

Intra-Patient Variability in Adalimumab Drug Levels Within and Between Cycles in Crohn's Disease

Editorial: Variability in Adalimumab Trough and Peak Serum Concentrations - Authors’ Reply

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Systematic Review: Exercise-Induced Gastrointestinal Syndrome-Implications for Health and Intestinal Disease

Review Article: Short Chain Fatty Acids as Potential Therapeutic Agents in Human Gastrointestinal and Inflammatory Disorders

Randomised Clinical Trial: Efficacy, Safety and Dosage of Adjunctive Allopurinol in Azathioprine/Mercaptopurine Nonresponders (AAA Study)

Editorial: Rethinking Predictors of Response to the Low FODMAP Diet - Should We Retire Fructose and Lactose Breath-Hydrogen Testing and Concentrate on Visceral Hypersensitivity?